Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Ignace Vergote | Researchclopedia

Back to researchers

Ignace Vergote

Gynecologic Oncology Group ORCID

1,880

Works

89,564

Citations

135

h-index

773

i10-index

Research Topics

Ovarian cancer diagnosis and treatment Endometrial and Cervical Cancer Treatments PARP inhibition in cancer therapy

Affiliations

Université Claude Bernard Lyon 12014–2019

Università Cattolica del Sacro Cuore2005–2005

Dartmouth College2013–2016

Délégation Paris 52010–2010

University of Geneva2010–2010

Top Works

Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer

Ignace Vergote,Claes G. Tropé,et al.

20102,487 citations

Intraperitoneal and Appendiceal Malignancies

Uterine Myomas and Treatments

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer

Mansoor R. Mirza,Bradley J. Monk,et al.

20162,418 citations

Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

Antonio González-Martı́n,Bhavana Pothuri,et al.

20192,186 citations

Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer

Isabelle Ray‐Coquard,Patricia Pautier,et al.

20191,970 citations

Epithelial ovarian cancer

Stéphanie Lheureux,Charlie Gourley,et al.

20191,879 citations

Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer

Jonathan A. Ledermann,Philipp Harter,et al.

20121,876 citations

ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma

Nicole Concin,Xavier Matías‐Guiu,et al.

20201,865 citations

Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial

Robert L. Coleman,Amit M. Oza,et al.

20171,678 citations

Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial

Éric Pujade-Lauraine,Felix Hilpert,et al.

20141,598 citations